241 related articles for article (PubMed ID: 28407569)
21. CD33(+) /HLA-DR(neg) and CD33(+) /HLA-DR(+/-) Cells: Rare Populations in the Human Decidua with Characteristics of MDSC.
Bartmann C; Junker M; Segerer SE; Häusler SF; Krockenberger M; Kämmerer U
Am J Reprod Immunol; 2016 May; 75(5):539-56. PubMed ID: 26840716
[TBL] [Abstract][Full Text] [Related]
22. The Frequency and Effect of Granulocytic Myeloid-Derived Suppressor Cells on Mycobacterial Survival in Patients With Tuberculosis: A Preliminary Report.
Davids M; Pooran A; Smith L; Tomasicchio M; Dheda K
Front Immunol; 2021; 12():676679. PubMed ID: 34149712
[TBL] [Abstract][Full Text] [Related]
23. TGF-β Enhances the Anti-inflammatory Effect of Tumor- Infiltrating CD33+11b+HLA-DR Myeloid-Derived Suppressor Cells in Gastric Cancer: A Possible Relation to MicroRNA-494.
Moaaz M; Lotfy H; Elsherbini B; Motawea MA; Fadali G
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3393-3403. PubMed ID: 33247701
[TBL] [Abstract][Full Text] [Related]
24. Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines.
Lechner MG; Megiel C; Russell SM; Bingham B; Arger N; Woo T; Epstein AL
J Transl Med; 2011 Jun; 9():90. PubMed ID: 21658270
[TBL] [Abstract][Full Text] [Related]
25. Human trophoblast cells induced MDSCs from peripheral blood CD14(+) myelomonocytic cells via elevated levels of CCL2.
Zhang Y; Qu D; Sun J; Zhao L; Wang Q; Shao Q; Kong B; Zhang Y; Qu X
Cell Mol Immunol; 2016 Sep; 13(5):615-27. PubMed ID: 26027727
[TBL] [Abstract][Full Text] [Related]
26. Expansion of polymorphonuclear myeloid-derived suppressor cells in patients with end-stage renal disease may lead to infectious complications.
Xing YF; Cai RM; Lin Q; Ye QJ; Ren JH; Yin LH; Li X
Kidney Int; 2017 May; 91(5):1236-1242. PubMed ID: 28215666
[TBL] [Abstract][Full Text] [Related]
27. Healthy myeloid-derived suppressor cells express the surface ectoenzyme Vanin-2 (VNN2).
Soler DC; Kerstetter-Fogle A; Young AB; Rayman P; Finke JH; Debanne SM; Cooper KD; Barnholtz-Sloan J; Sloan AE; McCormick TS
Mol Immunol; 2022 Feb; 142():1-10. PubMed ID: 34953280
[TBL] [Abstract][Full Text] [Related]
28. Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab.
Sade-Feldman M; Kanterman J; Klieger Y; Ish-Shalom E; Olga M; Saragovi A; Shtainberg H; Lotem M; Baniyash M
Clin Cancer Res; 2016 Dec; 22(23):5661-5672. PubMed ID: 27178742
[TBL] [Abstract][Full Text] [Related]
29. In neonates S100A8/S100A9 alarmins prevent the expansion of a specific inflammatory monocyte population promoting septic shock.
Heinemann AS; Pirr S; Fehlhaber B; Mellinger L; Burgmann J; Busse M; Ginzel M; Friesenhagen J; von Köckritz-Blickwede M; Ulas T; von Kaisenberg CS; Roth J; Vogl T; Viemann D
FASEB J; 2017 Mar; 31(3):1153-1164. PubMed ID: 27993995
[TBL] [Abstract][Full Text] [Related]
30. IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.
Chen MF; Kuan FC; Yen TC; Lu MS; Lin PY; Chung YH; Chen WC; Lee KD
Oncotarget; 2014 Sep; 5(18):8716-28. PubMed ID: 25238263
[TBL] [Abstract][Full Text] [Related]
31. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.
Jordan KR; Kapoor P; Spongberg E; Tobin RP; Gao D; Borges VF; McCarter MD
Cancer Immunol Immunother; 2017 Apr; 66(4):503-513. PubMed ID: 28108766
[TBL] [Abstract][Full Text] [Related]
32. Persistent accumulation of circulating monocytic myeloid-derived suppressor cells contributes to post-infectious immunosuppression in renal transplant recipients with bacterial infection: A pilot study.
Jiang Y; Feng S; Ji J; Lin Z; Zhang X
Transpl Immunol; 2018 Jun; 48():10-17. PubMed ID: 29477752
[TBL] [Abstract][Full Text] [Related]
33. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
[TBL] [Abstract][Full Text] [Related]
34. Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals.
Qin A; Cai W; Pan T; Wu K; Yang Q; Wang N; Liu Y; Yan D; Hu F; Guo P; Chen X; Chen L; Zhang H; Tang X; Zhou J
J Virol; 2013 Feb; 87(3):1477-90. PubMed ID: 23152536
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.
Ren JP; Zhao J; Dai J; Griffin JW; Wang L; Wu XY; Morrison ZD; Li GY; El Gazzar M; Ning SB; Moorman JP; Yao ZQ
Immunology; 2016 Aug; 148(4):377-86. PubMed ID: 27149428
[TBL] [Abstract][Full Text] [Related]
36. Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.
Zhang H; Li ZL; Ye SB; Ouyang LY; Chen YS; He J; Huang HQ; Zeng YX; Zhang XS; Li J
Cancer Immunol Immunother; 2015 Dec; 64(12):1587-99. PubMed ID: 26497849
[TBL] [Abstract][Full Text] [Related]
37. Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients.
Jordan KR; Amaria RN; Ramirez O; Callihan EB; Gao D; Borakove M; Manthey E; Borges VF; McCarter MD
Cancer Immunol Immunother; 2013 Nov; 62(11):1711-22. PubMed ID: 24072401
[TBL] [Abstract][Full Text] [Related]
38. Increased frequencies of CD11b(+) CD33(+) CD14(+) HLA-DR(low) myeloid-derived suppressor cells are an early event in melanoma patients.
Rudolph BM; Loquai C; Gerwe A; Bacher N; Steinbrink K; Grabbe S; Tuettenberg A
Exp Dermatol; 2014 Mar; 23(3):202-4. PubMed ID: 24495013
[TBL] [Abstract][Full Text] [Related]
39. Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion.
Luan Y; Mosheir E; Menon MC; Wilson D; Woytovich C; Ochando J; Murphy B
Am J Transplant; 2013 Dec; 13(12):3123-31. PubMed ID: 24103111
[TBL] [Abstract][Full Text] [Related]
40. [The expression and association of CD14(+) HLA-DR(Low/-) myeloid-derived suppressor cell-like cells and interleukin-1β in ovarian cancer].
Wang HY; Zhao R; Ren H; Zou MJ; Zhang J; Zhang Y
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2663-2669. PubMed ID: 28910953
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]